Beyond Vulnerability: Nonprofit Capital Capacity and Instrument Fit — Evidence from Two Complete National Registers

Nonprofit finance scholarship measures organisational health through vulnerability, sustainability and revenue diversification. None of these constructs answers a prior question: what kinds of capital can a nonprofit organisation structurally absorb at all? Debt and equity impose different preconditions before they impose prices, and an organisation failing a precondition is not an expensive borrower but one outside the instrument's domain at any price. We develop a two-dimensional framework separating capital capacity—the ability to service a fixed, scheduled claim—from commerciality—the share of revenue arriving through market exchange—and apply it at the entity level to two complete administrative registers: every financially-reporting Australian charity (n = 45,185) and every currently-filing United States public charity submitting a full Form 990 (n = 283,771), scored on up to twelve years of filings. The two dimensions are distinct and nowhere positively related, and the largest group in both countries occupies the corner whose preconditions conventional instruments are not built to meet: 52.6% of Australian and 48.6% of United States organisations can service a scheduled claim while generating almost no market income, a 4.0-point gap across two regulators and two reporting instruments with no re-tuning between them. Commerciality does not substitute for capacity. In these population data greater commerciality is not associated with greater capital capacity, and in the Australian register it is associated with thinner margins and more frequent deficits: organisations earning more than 80% of revenue from market exchange record a median surplus margin of 3.2% and run deficits at 34.3%, against 10.3% and 23.6% for organisations earning nothing. We further show that the standard practice of scoring organisations on their latest filing misclassifies one-off capital transfers as recurring revenue. Estimating the distortion requires care—the obvious comparison of latest year to median year measures growth as much as windfall—but after detrending each organisation against its own filed history and isolating the tail that departs from it, 4.5% of the apparent revenue of the United States contributions-dominant focal cell—$25 bn—proves non-recurring, concentrated in under 7% of its organisations. This is a figure for that cell, not for the sector. The findings relocate a large part of the nonprofit sector from financially weak to structurally mismatched to available instruments. This is a claim about structural admissibility, not about observed credit rationing—no capital allocation decision appears anywhere in these data, and we show that a population sits outside the shape of existing instruments, never that any organisation within it sought capital and was refused. We argue the field should treat capital capacity and funding channel as one object in two dimensions rather than collapsing both into financial health, since each axis is the precondition of a different instrument family and reach depends on the pair; and should treat the absence of a fitting instrument as a distinct object of study from organisational weakness, since the two imply different interventions and the second is at present much the better developed of the two.